Skip to main content

Femasys Inc

FEMY
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001339005

In the last 90 days, Femasys Inc insiders filed 5 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $8.65M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Femasys Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of FEMY: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders1110−1
Shares601.2K523.0K−78.3K (−13.0%)
Value$4.90M$3.60M−$1.30M (−26.5%)

New holders (6)

Institutions that held Femasys Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to FEMY in Q3 2021
InstitutionSharesValue% of portfolio
Clear Creek Financial Management, LLC23,524$162.0K0.03%
BlackRock Inc.5,894$40.0K0.00%
Royal Bank of Canada2,223$15.0K0.00%
Tower Research Capital LLC (TRC)683$5.00K0.00%
Morgan Stanley278$2.00K0.00%
Wells Fargo & Company17$00.00%

Sold out (7)

Institutions that held Femasys Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of FEMY in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
PVG Asset Management Corp42,400$343.9K
Envestnet Asset Management Inc22,748$184.0K
Maven Securities LTD19,189$184.0K
Schonfeld Strategic Advisors LLC12,900$105.0K
Gillson Capital LP9,826$80.0K
UBS Group AG5,188$42.0K
Advisor Group Holdings, Inc.1,714$14.0K